A novel signaling molecule for neuropeptide action: Activity-dependent neuroprotective protein

Annals of the New York Academy of Sciences

Volumn 897, Issue , 1999, Pages 125-135

  Gozes, Illana ^a,b   Bassan, Merav ^a   Zamostiano, Rachel ^a   Pinhasov, Albert ^a   Davidson, Ariane ^a   Giladi, Eliezer ^a   Perl, Orly ^a   Glazner, Gordon W ^b   Brenneman, Douglas E ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METALLOPROTEIN; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; ZINC;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ASTROCYTE; BINDING SITE; BRAIN CELL; CEREBELLUM; CONFERENCE PAPER; HIPPOCAMPUS; MOUSE; NEUROPROTECTION; NONHUMAN; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0033398895     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07884.x     Document Type: Conference Paper

References (56)

1. 1. Gozes, I. & D.E. Brenneman. 1989. VIP molecular biology and neurobiological function. Molec. Neurobiol. 3: 201-236.
2. 2. Said, S.I. 1996. Molecules that protect: the defense of neurons and other cells. J. Clin. Invest. 97: 2163-2164.
3. 3. Brenneman, D.E., J.M. Hill, P. Gressens & I. Gozes. 1998. Neurotrophic action of VIP: from CNS ontogony to therapeutic strategy. In Proinflammatory and Anti inflammatory Peptides. S.I. Said, Ed.: 383-408. Marcel Dekker, Inc. New York.
4. 4. Brenneman, D.E. & L. E. Eiden. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83: 1159-1162.
5. 5. Gozes, I., A. Bardea, A. Reshef, R. Zamostiano S. Zhukovsky, S. Rubinraut, M. Fridkin & D.E. Brenneman. 1996. Novel neuroprotective strategy for Alzheimers disease: inhalation of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
6. 6. Brenneman D.E., G.L. Westbrook, S.P. Fitzgerald, D.L. Ennist, K.L. Elkins, M.R. Ruff & C.B. Pert 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
7. 7. Glowa, J.R., L.V. Panlilio, D.E. Brenneman, I. Gozes, M. Fridkin & J.M. Hill. 1992. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 570: 49-53.
8. 8. Gozes, I., J. Glowa, D.E. Brenneman, S.K. McCune, E. Lee & H. Westphal. 1993. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 4: 185-193.
9. 9. Hill, J.M., I. Gozes, J.L. Hill, M. Fridkin & D.E. Brenneman. 1991. Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides 12: 187-192.
10. 10. Gozes, I., M. Bachar, A. Bardea, A. Davidson, S. Rubinraut, M. Fridkin & E. Giladi. 1997. Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implication for early treatment of Alzheimer's disease. J. Neurobiol. 33: 329-342.
11. 11. Brenneman, D.E., E.A. Neale., G.A. Foster, S.W. D'Autremont & G.L. Westbrook. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide J. Cell Biol. 104: 1603-1610.
12. 12. Brenneman, D.E., T. Nicol, D. Warren & L.M. Bowers. 1990. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25: 386-394.
13. 13. Gozes, I. & D.E. Brenneman. 1993. Neuropeptides as growth and differentiation factors in general and VIP in particular. J. Molec. Neurosci. 4:1-9.
14. 14. Brenneman, D.E. & I. Gozes. 1996. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97: 2299-2307.
15. 15. Gozes, I. & D.E. Brenneman. 1996. Activity-dependent neurotrophic factor ADNF: an extracellular neuroprotective chaperonin? J. Molec. Neurosci. 7: 235-244.
16. 16. Gozes, I., A. Davidson, Y. Gozes, R. Mascolo, R. Barth, D. Warren, J. Hauser & D.E. Brenneman. 1997. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: Immunological and biological specificity. Dev. Brain Res. 99: 167-175.
17. 17. Brenneman, D.E., J. Hauser, E.A. Neale, S. Rubinraut, M. Fridkin, A. Davidson & I. Gozes. 1998. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J. Pharmacol. Exp. Ther. 285: 619-627.
18. 18. Bassan, M., R. Zamostiano, A. Davidson, A. Pinhasov, E. Giladi, O. Perl, H. Bassan, C. Blat, G. Gibney, G. Glazner, D.E. Brenneman & I. Gozes. 1999. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72: 1283-1293.
19. 19. Zhao, D., P. McCaffery, K.J. Ivins, R.L. Neve, P. Hogan, W.W. Chin & U.C. Drager. 1996. Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. Eur. J. Biochem. 240: 15-22.
20. 20. Rosenfeld, R. & H. Margalit. 1993. Zinc fingers: conserved properties that can distinguish between spurious and actual DNA-binding motifs. J. Biomol. Struct. Dyn. 11: 557-570.
21. 21. Johnson, G.P., S.J. Goebel, M.E. Perkus, S.W. Davis, J.P. Winslow & E. Paoletti. 1991. Vaccinia virus encodes a protein with similarity to glutaredoxins. Virology 181: 378-381.
22. 22. Chou, P.Y. & G.D. Fasman. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47: 45-148.
23. 23. Chang, C., A.G. Saltzman, R.A. Hiipakka, I.Y. Huang & S. Liao. 1987. Prostatic spermine-binding protein. Cloning and nucleotide sequence of cDNA, amino acid sequence, and androgenic control of mRNA level. J. Biol. Chem. 262: 11901-11903.
24. 24. Chestukhin, A., L. Litovchick, K. Muradov, M. Batkin & S. Shaltiel. 1997. Unveiling the substrate specificity of meprin β on the basis of the site in protein kinase A cleaved by the kinase splitting membranal proteinase. J. Biol. Chem. 272: 3153-3160.
25. 25. Taira, M., W.P. Hayes, H. Otani & I.B. Dawid. 1993. Expression of LIM class homeobox gene Xlim-3 in Xenopus development is limited to neural and neuroendocrine tissues. Dev. Biol. 159: 245-256.
26. 26. Gozes, I., S.K. McCune, L. Jacobson, D. Warren, T.W. Moody, M. Fridkin & D.E. Brenneman. 1991. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959-66.
27. 27. Brenneman, D.E., M. Schultzberg, T. Bartfai & I. Gozes. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 5: 454-460.
28. 28. Brenneman, D.E., J.M. Hill, G.W. Glazner, I. Gozes & T.W. Phillips. 1995. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13: 187-210.
29. 29. Festoff, B.W., P.G. Nelson & D.E. Brenneman. 1996. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin-1. J. Neurobiol. 30: 255-266.
30. 30. Bassan, M., R. Zamostiano, E. Giladi, A. Davidson, Y. Wollman, J. Pitman, J. Hauser, D.E. Brenneman & I. Gozes. 1998. The identification of secreted heat shock 60-like protein from rat glial cells and a human neuroblastoma cell line. Neurosci. Letters 249: 1-4.
31. 31. Clos, J. & E. Dicou. 1997. Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo. Dev. Brain Res. 99: 267-270.
32. 32. Dicou, E., B. Pflug, M. Magazin, T. Lehy, D. Djakiew, P. Ferrara, V. Nerriere & D. Harvie. 1997. Two peptides derived from the nerve growth factor precursor are biologically active. J. Cell Biol. 136: 389-398.
33. 33. Bockova, J., D. Elias & I.R. Cohen. 1997. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J. Autoimmun. 10: 323-329.
34. 34. Schwartz, J.P. 1998. Development and plasticity. Overview. Adv. Pharmacol. 42: 877-882.
35. 35. McDonald, M.P. & J.N. Crawley. 1997. Galanin-acetylcholine interactions in rodent memory tasks & Alzheimer's disease. J. Psychiatry Neurosci. 22: 303-217.
36. 36. Selkoe, D.J. 1993. Physiological production of the beta amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16: 403-409.
37. 37. Lipton, S.A., N.J. Sucher, P.K. Kaiser & E.B. Dreyer. 1991. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7: 111-118.
38. 38. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin & J.L. Breslow. 1992. Severe Hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
39. 39. Gordon, I., E. Grauer, I, Genis, E. Sehayek & D.M. Michaelson. 1995. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199: 1-4.
40. 40. Masliah, E., M. Mallory, N. Ge, M. Alford, I. Veinbergs & A. Roses. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136: 107-122.
41. 41. Masliah, E., W. Samuel, I. Veinbergs, M. Mallory, M. Mante & T. Saitoh. 1997. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751: 307-314.
42. 42. Oitzl, M.S., M. Mulder, P.J. Lucassen, L.M. Havekes, J. Grootendorst & E.R. De Kloet. 1997. Severe learning deficits in apolipoprotein E knockout mice in a water maze task. Brain Res. 752: 189-196.
43. 43. Fisher, A. R. Brandeis, S. Chapman, Z. Pittel. & D.M. Michaelson. 1998. MI muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J. Neurochem. 70: 1991-1997.
44. 44. Chapman, S. & D.M. Michaelson. 1998. Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J. Neurochem. 70: 708-714.
45. 45. Weisgraber, K.H., R.E. Pitas & R.W. Mahley. 1994. Lipoproteins, neurobiology, & Alzheimer's disease: structure & function of apolipoprotein E. Curr. Opin. Struct. Biol. 4: 507-515.
46. 46. Gozes, I., M. Bassan, R. Zamostiano, A. Davidson, O. Perl, H. Bassan, C. Blat, E. Giladi, G. Gibney, G. Glazner & D.E. Brenneman. 1997. A femtomolar-acting activity-dependent neuroprotective protein (ADNP). Neurosci. Lett. Suppl. 48: S21.
47. 47. Zamostiano, R., M. Bassan, A. Davidson, D.E. Brenneman & I. Gozes. 1997. A human homologue for activity-dependent neuroprotective protein Neurosci. Lett. Suppl. 48: S54.
48. 48. Giladi, E., A. Davidson, M. Bachar, A. Bardea, S. Rubinraut, M. Fridkin, D.E. Brenneman & I. Gozes. 1997. Protection against developmental and learning impairments in apolipoprotein E-deficient mice by activity-dependent femtomolar-acting peptides. Neurosci. Lett. Suppl. 48: S19.
49. 49. Beni-Adani L, S. Pomeranz, I. Gozes, M. Bassan D.E. Brenneman & E. Shohami. 1997. The neuroprotective effect of activity dependent neurotrophic protein in mice after closed head injury. Neurosci. Lett. Suppl. 48: S9-S10.
50. 50. Pelsman, A., G. Fernandez, I. Gozes, D.E. Brenneman & J. Busciglio. 1998. Activity-dependent neurotrophic factor peptides prevent degeneration of Down's syndrome neurons grown in culture. J. Neurochem. 71 (Suppl. 1): S54.
51. 51. Markesbery, W.R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23: 134-147.
52. 52. Mark, R.J., E.M. Blanc & M.P. Mattson. 1996. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12: 211-224.
53. 53. Schapira, A.H. 1996. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9: 260-264.
54. 54. Cafe, C., C. Tori, L. Bertorelli, N. Angeretti, E. Lucca, G. Forloni & F. Marzatico. 1996. Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures. Neurosci. Lett. 203: 61-65.
55. 55. Glazner, G.W., D.E. Brenneman, I. Gozes & M.P. Mattson. 1997. A 9 amino acid peptide fragment of activity-dependent neurotrophic factor (ADNF) protects neurons from oxidative stress-induced death. Soc. Neurosci. Abstr. 23: 2249.
56. 56. Pellegri, G., P.J. Magistretti & J.L. Martin. 1998. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones Eur. J. Neurosci. 10: 272-280.